European Investor
01 May 2026, 14:16
Colgate Announces 1st Quarter 2026 Results
Shares of Colgate-Palmolive Company rose 3.44% to $88.38 today, as investors reacted positively to the company’s first-quarter 2026 earnings, which highlighted solid underlying growth and resilient brand performance despite mixed headline metrics.
Colgate reported net sales of $5.3 billion, up 8.4% year-over-year, supported by pricing actions and favorable currency effects. Organic sales growth came in at 2.9%, reflecting balanced contributions from volume and pricing across most categories and regions, even as the exit from private label pet food created a modest drag.
While GAAP earnings showed some pressure, underlying profitability remained strong. Diluted EPS declined 6% to $0.80, but Base Business EPS—a key adjusted metric—rose 7% to $0.97, indicating continued operational strength and margin discipline beneath the surface.
Gross margins softened slightly, with both GAAP and Base Business gross profit margin declining 20 basis points to 60.6%. This reflects ongoing cost pressures and investments, including increased advertising spending aimed at supporting long-term brand growth.
Cash generation remained solid, with operating cash flow reaching $747 million in the quarter. The company also highlighted improvements in operating profit, net income, and free cash flow on an adjusted basis, reinforcing confidence in its business model.
From a market position standpoint, Colgate maintained its global leadership in oral care. Toothpaste market share stood at 41.1% year-to-date, while manual toothbrush share reached 32.6%, underscoring the strength of its core franchise.
CEO Noel Wallace emphasized that the company delivered a “strong start” to the year, citing broad-based growth across categories and geographies. He also pointed to the resilience of Colgate’s operating model amid a challenging macroeconomic environment.
Strategically, the company announced an expansion of its Strategic Growth and Productivity Program (SGPP), increasing expected cumulative restructuring charges to $350 million–$550 million, while targeting annual savings of $200 million–$300 million once fully implemented. This initiative is designed to enhance efficiency and support long-term growth under its 2030 strategy.
Looking ahead, Colgate reaffirmed its 2026 outlook, expecting net sales growth of 2% to 6% and organic sales growth of 1% to 4%. However, the company revised its gross margin expectation downward, now anticipating a decline for the full year, while still projecting low- to mid-single-digit adjusted EPS growth.
Overall, despite some margin pressure and a decline in reported EPS, investors appeared to focus on the company’s solid organic growth, strong brand leadership, and continued earnings expansion on an adjusted basis—factors that likely drove the positive move in the stock.
Shares of Colgate-Palmolive Company rose 3.44% to $88.38 today, as investors reacted positively to the company’s first-quarter 2026 earnings, which highlighted solid underlying growth and resilient brand performance despite mixed headline metrics.
Colgate reported net sales of $5.3 billion, up 8.4% year-over-year, supported by pricing actions and favorable currency effects. Organic sales growth came in at 2.9%, reflecting balanced contributions from volume and pricing across most categories and regions, even as the exit from private label pet food created a modest drag.
While GAAP earnings showed some pressure, underlying profitability remained strong. Diluted EPS declined 6% to $0.80, but Base Business EPS—a key adjusted metric—rose 7% to $0.97, indicating continued operational strength and margin discipline beneath the surface.
Gross margins softened slightly, with both GAAP and Base Business gross profit margin declining 20 basis points to 60.6%. This reflects ongoing cost pressures and investments, including increased advertising spending aimed at supporting long-term brand growth.
Cash generation remained solid, with operating cash flow reaching $747 million in the quarter. The company also highlighted improvements in operating profit, net income, and free cash flow on an adjusted basis, reinforcing confidence in its business model.
From a market position standpoint, Colgate maintained its global leadership in oral care. Toothpaste market share stood at 41.1% year-to-date, while manual toothbrush share reached 32.6%, underscoring the strength of its core franchise.
CEO Noel Wallace emphasized that the company delivered a “strong start” to the year, citing broad-based growth across categories and geographies. He also pointed to the resilience of Colgate’s operating model amid a challenging macroeconomic environment.
Strategically, the company announced an expansion of its Strategic Growth and Productivity Program (SGPP), increasing expected cumulative restructuring charges to $350 million–$550 million, while targeting annual savings of $200 million–$300 million once fully implemented. This initiative is designed to enhance efficiency and support long-term growth under its 2030 strategy.
Looking ahead, Colgate reaffirmed its 2026 outlook, expecting net sales growth of 2% to 6% and organic sales growth of 1% to 4%. However, the company revised its gross margin expectation downward, now anticipating a decline for the full year, while still projecting low- to mid-single-digit adjusted EPS growth.
Overall, despite some margin pressure and a decline in reported EPS, investors appeared to focus on the company’s solid organic growth, strong brand leadership, and continued earnings expansion on an adjusted basis—factors that likely drove the positive move in the stock.
